Genetic variants may affect the risk of breast cancer in women with BRCA2 mutations

Oct 28, 2010

An international study led by researchers at Memorial Sloan-Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer. The study was published today online in the open-access journal PLoS Genetics.

The findings of the study suggest that genetic variants on chromosomes 10 and 20 may modify risk for breast cancer among women with a BRCA2 mutation.

Researchers analyzed DNA samples from 6,272 women with BRCA2 mutations in a two-stage genome-wide association study. The chromosome 10 variant identified in the study, near the gene ZNF365, decreased the risk of breast cancer by approximately 25 percent in women also carrying a mutation of the BRCA2 gene. The current study and a recent report published in found that variants near the same gene, ZNF365, affect breast cancer risk in the general population. While BRCA2 mutations are rare, the ZNF365 variant is more common, seen in one in ten individuals. In addition, researchers found that other variants, including FGFR2, recognized to increase breast cancer risk in the general population, also served as risk modifiers for women with BRCA2 mutations.

"The risk of breast cancer associated with BRCA2 mutations varies widely. Our goal in this study was to test the hypothesis that common genetic variants may modify cancer risk in those already carrying 'high risk' mutations," said the study's senior author, Kenneth Offit, MD, MPH, Chief of the Clinical Genetics Service at Memorial Sloan-Kettering. "It's interesting that our study of BRCA2 and a companion study of BRCA1 both found that women with BRCA mutations likely have the same risk modifiers for breast cancer as women in the general population."

While the authors state that these findings do not have any immediate clinical implications, the discovery of these risk modifiers for women with BRCA2 mutations is important for further research into the role of genetic causes of .

Explore further: Refining the language for chromosomes

Provided by Memorial Sloan-Kettering Cancer Center

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Study points to new breast cancer-susceptibility gene

Feb 08, 2007

A gene whose existence was detected only a couple of years ago may increase women’s risk of breast cancer when inherited in a mutated form, and may contribute to prostate cancer as well, researchers at Dana-Farber Cancer ...

Recommended for you

Refining the language for chromosomes

20 hours ago

When talking about genetic abnormalities at the DNA level that occur when chromosomes swap, delete or add parts, there is an evolving communication gap both in the science and medical worlds, leading to inconsistencies in ...

Down's chromosome cause genome-wide disruption

Apr 16, 2014

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

User comments : 0

More news stories

LADEE mission ends with planned lunar impact

(Phys.org) —Ground controllers at NASA's Ames Research Center in Moffett Field, Calif., have confirmed that NASA's Lunar Atmosphere and Dust Environment Explorer (LADEE) spacecraft impacted the surface ...

A full-spectrum Mars simulation in a box

There are many reasons why Mars excels at destroying expensive equipment. For one thing, its entire surface is made of partially-magnetized dust. For another, Mars possesses just enough atmosphere so that ...